Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

EMPOWERing Patients with Type 2 Diabetes Mellitus (T2DM) in Primary Care Through App-based Motivational Interviewing PLUS Artificial Intelligence Powered Diabetes Management (EMPOWER-PLUS): Randomised Controlled Trial

NCT06214520 is registered in ClinicalTrials.gov with Singapore General Hospital as lead sponsor.

NCT NCT06214520
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06214520 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
EMPOWERing Patients with Type 2 Diabetes Mellitus (T2DM) in Primary Care Through App-based Motivational Interviewing PLUS Artificial Intelligence Powered Diabetes Management (EMPOWER-PLUS): Randomised Controlled Trial
Lead sponsor
Singapore General Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
February 23, 2024
Completion date
June 30, 2026
Enrollment
525 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus type 2